“…Serious complications of intramuscular deltoid injections are rare, whereas abscesses and granulomas are more common with subcutaneous injections. 3,4 In studies comparing adverse effects of the Diphtheria, Pertussis, and Tetanus (DPT) vaccine associated with different needle lengths, use of longer needles was associated with less pain following immunisation of infants in the thigh. 17,18 The use of shorter needles resulted in deposition of vaccine into the subcutaneous tissue, which is well innervated with pain fibres compared to muscle tissue.…”
“…Serious complications of intramuscular deltoid injections are rare, whereas abscesses and granulomas are more common with subcutaneous injections. 3,4 In studies comparing adverse effects of the Diphtheria, Pertussis, and Tetanus (DPT) vaccine associated with different needle lengths, use of longer needles was associated with less pain following immunisation of infants in the thigh. 17,18 The use of shorter needles resulted in deposition of vaccine into the subcutaneous tissue, which is well innervated with pain fibres compared to muscle tissue.…”
“…또 피하지방은 근육보다 혈액 공급이 적고 배액이 잘 되지 않아 농양이나 육아종이 더 잘 발 생할 수도 있다 (Chan et al, 2006;Haramati et al, 1994;Poland et al, 1997) (Burbridge, 2007;Chan et al, 2006;Haramati et al, 1994;Lippert & Wall, 2008;Nisbet, 2006;Poland et al, 1997;Rai & Nandan, 2006;Zaybak et al, 2007) …”
Purpose:To study the thickness of gluteal subcutaneous fat (SCF) and propose an adequate length for needle for gluteal intramuscular injections based on computed tomography (CT) measurements. Methods: The thickness of gluteal SCF were measured and studied for 568 patients who visited a tertiary hospital in Seoul, Korea between January 2007 and February 2009 for routine health screening and who had abdominopelvic CT. Results: The average thickness of gluteal SCF was 15.92±4.08 mm in males and 24.90±5.47 mm in females. The thickness of gluteal SCF differed significantly according to gender. The gluteal SCF thickness was greater than 20.4 mm for 54 (12.3%) of the 440 male patients and 99 (77.3%) of the 128 female patients. Conclusion: The most common syringe needle used for gluteal intramuscular injections in Korea is a 23 G, 25.4 mm-needle. The SCF thickness must be less than 20.4 mm in order to reach the dorsogluteal muscles to a depth of at least 5 mm if this 25.4 mm needle is used. In many patients, especially in female patients, the 25.4 mm needles will result in improper intramuscular injections with the injection being into the SCF. Therefore an appropriate needle should be selected by considering the gender and SCF thickness of patients receiving gluteal intramuscular injections.
“…Logistic regression was conducted to identify risk factors for adverse events while controlling for demographic factors, comorbidities, and injection-related risk factors. For the logistic regression model, variables found to be statistically significant in the univariate analysis and variables that have been identified in the literature to be significant risk factors such as gender, age, vial age at injection, and underlying diabetes were included in the final model [1,8,[13][14][15]. All data in this investigation were analyzed using Epi Info 7.1.2.0 (CDC, Atlanta, GA).…”
Objective: Identify injection-site abscesses and quantify risk factors from injections with subsequently recalled preservative-free Methylprednisolone acetate (pf-MPA) from Main Street Family Pharmacy (MSFP).
Design:Outbreak investigation and retrospective cohort study.
Setting:Private primary healthcare facility.Patients: Three hundred and seven patients that received pf-MPA injections manufactured by MSFP from December 1, 2012 through February 28, 2013.Methods: Medical records were abstracted for individuals with an adverse event and individuals with known exposure to pf-MPA lots 011413dan and 120612dan. Records were analyzed for factors related to injection-site adverse events using logistic regression. Facility records from 2006 through 2013 were queried for International Classification of Diseases, 9 th edition, Clinical Modification (ICD-9-CM) diagnosis codes 682.5 and 680.5 to identify additional adverse events.
Results:Sixteen of 307 injected individuals (attack rate = 5.2%) were identified with adverse events consisting of soft tissue infections at the injection site. Increasing body mass index (BMI) (odds ratio [OR] =1.17; 95% CI=1.04-1.33), age of vial at injection (OR=1.13; 95% CI=1.00-1.27), and date of injection (OR=10.01; 95% CI=1.49-67.11) were associated with adverse events.
Conclusion:Risk of soft tissue infections following injection of recalled MSFP pf-MPA was greater among persons with higher BMI, receiving older product, and receiving injections from February 5 through February 15, 2013. Appropriate needle length was not used for patients with a greater BMI. A written protocol for pf-MPA injections including needle length and gauge should be created and trainings on this protocol provided to staff administering injections. Compounded pharmaceuticals, especially preservative-free formulations, should not be utilized for multiple injections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.